ֱ

New Drug for Gastric Ulcers; Linzess for Kids' Constipation; IBD Meds Safe in Utero

— News and commentary from the world of gastroenterology and hepatology

MedpageToday
Gastro Roundup over a computer rendering of an endoscope.

The FDA approved an oral suspension product that combines omeprazole and sodium bicarbonate (Konvomep) to and reduce the risk of upper gastrointestinal bleeds in critically ill patients, Azurity Pharmaceuticals announced.

Topline results from a phase III trial showed linaclotide (Linzess) met both primary and secondary endpoints, showing improvements in frequency of ages 6 to 17 with functional constipation, Ironwood Pharmaceuticals announced.

Inflammatory bowel disease (IBD) and the are linked. (Clinical Gastroenterology and Hepatology)

in Crohn's disease and ulcerative colitis. (Digestive Diseases and Sciences)

Patients with IBD were more likely to be if they also had diabetes, according to a meta-analysis in Digestive and Liver Disease.

Dupilumab (Dupixent) was safe and effective for who had atopic dermatitis or dermatitis that was induced or worsened by the use of tumor necrosis factor inhibitors. (Digestive Diseases and Sciences)

was not linked to early-life malignancy compared with unexposed children, a French study found. (Clinical Gastroenterology and Hepatology)

Could the use of a with machine learning help differentiate esophageal and gastric cancer margins in real time during surgery? (JAMA Surgery)

Transcutaneous electrical stimulation of acupuncture points improved symptoms of by increasing both colon transit and the threshold for rectal sensation, according to a randomized trial from China. (American Journal of Gastroenterology)

Restarting infliximab (Remicade) treatment was safe and induced clinical remission for one-third of , regardless of the reason they had for stopping it before, a French study found. (American Journal of Gastroenterology)

  • author['full_name']

    Zaina Hamza is a staff writer for ֱ, covering Gastroenterology and Infectious disease. She is based in Chicago.